New Two-Pronged attack on tough pancreatic cancer begins human testing
Disease control
Not yet recruiting
This early-stage study aims to find out if a new two-part treatment is safe for people with locally advanced pancreatic cancer. First, patients receive a precise, high-dose radiation treatment. Then, they receive an experimental immunotherapy drug (PCX12) injected directly into t…
Phase: PHASE1 • Sponsor: Haoming (Carl) Qiu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC